Leprosy slowly attacks the protective cells surrounding your peripheral nerves, gradually destroying your ability to feel pain, temperature, and touch in the skin and extremities. It also causes distinctive skin patches and, if untreated, can lead to serious deformities of the hands, feet, and face. The disease is caused by a slow-growing bacterium and remains treatable with antibiotics, but nerve damage that occurs before treatment is often permanent.
How the Bacteria Targets Your Nerves
The bacterium responsible for leprosy, Mycobacterium leprae, has an unusual strategy. Rather than attacking immune cells like many infections, it targets Schwann cells, the cells that wrap around and insulate peripheral nerves throughout your body. Schwann cells provide a safe hiding place where the bacteria can survive and multiply largely shielded from the immune system.
Once inside, M. leprae essentially reprograms Schwann cells, reverting them to an immature, stem-cell-like state and causing them to multiply abnormally. This unchecked proliferation within the tight compartments surrounding nerve fibers creates swelling and pressure that slowly destroys the nerve fibers themselves. The result is a progressive loss of sensation that starts in the skin and can eventually affect deeper nerves controlling muscles. This nerve damage is what drives nearly every visible consequence of the disease.
What It Does to the Skin
The earliest and most recognizable sign of leprosy is one or more skin patches that are lighter than the surrounding skin or slightly reddened. These patches have a critical distinguishing feature: they are numb. You cannot feel a light touch, pinprick, or temperature change within the affected area. The patches also tend to be dry and hairless because the nerve damage disrupts sweat glands and hair follicles in that zone.
How the patches look depends on where the disease falls on a clinical spectrum. In milder forms, there may be only one to three well-defined patches with clear borders. In more severe forms, the skin develops widespread, symmetrical nodules and thickened areas. The face and ears are particularly affected, and heavy infiltration of the facial skin can create a thickened, furrowed appearance sometimes called “leonine facies.” The earlobes often become noticeably swollen and enlarged.
The Spectrum From Mild to Severe
Leprosy is not a single uniform disease. It exists on a spectrum determined largely by how effectively your immune system responds to the bacteria. At one end, the milder form (tuberculoid leprosy) reflects a strong immune response. The infection stays localized, producing a small number of numb skin patches and thickening of only one or two nearby nerves. Bacteria are so scarce in the skin that standard tests cannot detect them.
At the other end, lepromatous leprosy represents a severely weakened immune response that allows the bacteria to multiply unchecked throughout the body. Skin lesions are numerous and widespread, appearing symmetrically across the face, trunk, and limbs. Bacteria are abundant. Between these two poles lies borderline leprosy, an unstable middle ground where the disease can shift toward either extreme. Borderline patients may have a mix of well-defined and poorly defined patches, and their nerve involvement can be unpredictable.
How Nerve Damage Leads to Deformities
The loss of sensation itself is dangerous because you lose your body’s warning system. Without pain, you can burn your hands on a hot surface, step on a nail, or develop blisters from ill-fitting shoes without realizing it. These unnoticed injuries become infected, and repeated infections over time damage tissue and bone. This cycle of painless injury, infection, and tissue destruction is the primary reason people with untreated leprosy lose fingers and toes. The bacteria do not “eat away” the flesh as commonly imagined. Instead, the combination of numbness and repeated unnoticed trauma does the damage.
Direct bacterial invasion of bone does occur but is relatively rare, mostly affecting the small bones of the hands and feet. Far more common are bone changes secondary to nerve damage: muscle weakness causes bones to shift out of alignment, disuse leads to thinning of bone, and chronic infections erode tissue from the outside in.
Motor nerve damage produces specific deformities. When nerves supplying the small muscles of the hand are destroyed, the fingers curl into a fixed “claw” position because the muscles that straighten the finger joints no longer work. Damage to the nerve controlling the foot can cause “foot drop,” where the foot hangs limp and drags during walking. And when the facial nerve branch supplying the eyelid muscles is affected, the eyelids can no longer fully close, a condition called lagophthalmos. This leaves the eye’s surface exposed, leading to drying, ulceration, and potentially blindness if untreated.
How Leprosy Spreads
Leprosy is far less contagious than most people assume. It spreads through respiratory droplets when someone with untreated disease coughs or sneezes, but transmission requires prolonged, close contact over many months. Casual interactions, brief encounters, or touching someone with leprosy do not spread the disease.
About 95% of people are naturally immune. Their immune systems can eliminate the bacteria without ever developing symptoms. For the small percentage who are susceptible, the incubation period is extraordinarily long. The bacterium grows more slowly than almost any other known human pathogen, and it can take anywhere from a few years to 20 years after exposure before symptoms appear. This lengthy delay makes it difficult to pinpoint exactly when or where a person was infected.
Treatment and Recovery
Leprosy is curable. The World Health Organization recommends a combination of three antibiotics taken together, a regimen known as multidrug therapy. For milder cases with fewer skin lesions and lower bacterial counts, the treatment course lasts 6 months. For more severe cases with widespread involvement, treatment lasts 12 months. The bacteria are killed relatively quickly once treatment begins, and patients become noncontagious within days to weeks of starting medication.
The important caveat is that antibiotics stop the infection but do not reverse nerve damage that has already occurred. Sensation lost before treatment typically does not return. Muscle weakness and deformities that have already developed may require physical therapy, protective footwear, or reconstructive surgery. This is why early diagnosis matters so much. The sooner treatment starts, the less permanent damage the disease can cause.
Leprosy Today
Leprosy has not disappeared. Globally, about 180,000 new cases were reported in 2023, roughly 5% more than the previous year. The disease is concentrated in tropical and subtropical regions, with India, Brazil, and Indonesia accounting for the majority of cases. It also occurs at low levels in the southeastern United States, where exposure to wild armadillos (which carry the same bacterium) is a known risk factor.
The stigma surrounding leprosy often causes more suffering than the disease itself, discouraging people from seeking early treatment and leading to social isolation. In reality, leprosy caught early and treated promptly leaves no visible trace. The severe deformities historically associated with the disease are consequences of years or decades without treatment, not an inevitable outcome of infection.